Rh positive means your red blood cells carry a specific protein called the D antigen on their surface. Rh negative means they don’t. About 85% of people worldwide are Rh positive, making it the more common type. Your Rh status is one part of your blood type, written as the “+” or “-” after the letter (A+, O-, etc.), and it matters most during blood transfusions and pregnancy.
The Protein Behind Your Rh Status
The Rh factor refers to a protein embedded in the membrane of your red blood cells. This protein, called the D antigen, sits on a larger structure that threads through the cell membrane 12 times. It’s not just sitting on the surface like a sticker; it’s woven into the architecture of the cell itself. The D antigen has over 30 distinct sites where the immune system can recognize it, which is why it triggers such a strong immune response in people who lack it.
When a lab tests your blood type, they’re checking whether this protein is present. If it is, you’re Rh positive. If it’s absent, you’re Rh negative. The test is straightforward and is routinely done alongside ABO blood typing (the system that determines whether you’re type A, B, AB, or O).
How Rh Status Is Inherited
You inherit your Rh status from your parents, one gene copy from each. The Rh-positive gene is dominant, meaning it overrides the negative version. So you only need one copy of the positive gene to be Rh positive. To be Rh negative, you need two copies of the negative gene, one from each parent.
This creates some combinations that surprise people. Two Rh-positive parents can have an Rh-negative child if both carry one hidden copy of the negative gene. In that scenario, there’s roughly a 1-in-4 chance the child inherits the negative gene from both sides and ends up Rh negative. On the other hand, if both parents are Rh negative, all of their children will also be Rh negative, since neither parent has a positive gene to pass on.
How Common Each Type Is
Rh-negative blood is unevenly distributed around the world. In East Asian countries like China, Japan, and Indonesia, fewer than 1% of people are Rh negative. In parts of Africa, the rate ranges from about 1% to 7% depending on the region. European and North American populations have much higher rates: roughly 17% in Britain and 15% in the United States. The highest known prevalence comes from the Basque population and parts of Saudi Arabia, where about 29% of people are Rh negative.
These differences matter for blood banks. In regions where Rh-negative blood is rare, maintaining an adequate supply for transfusions is a constant challenge.
Why Rh Status Matters for Transfusions
If you’re Rh negative and receive Rh-positive blood, your immune system may recognize the D antigen as foreign and build antibodies against it. This process, called alloimmunization, doesn’t usually cause problems the first time. But once your body has made those antibodies, any future exposure to Rh-positive blood can trigger a transfusion reaction where your immune system attacks the donated red blood cells, destroying them. This can range from mild to life-threatening.
For this reason, Rh-negative patients receive Rh-negative blood whenever possible. Rh-positive patients can safely receive either Rh-positive or Rh-negative blood, since their immune system already recognizes the D antigen as normal. This is also why O-negative blood is considered the universal donor type for emergencies: it lacks both the ABO antigens and the D antigen, so it’s unlikely to provoke an immune reaction in anyone.
Rh Incompatibility in Pregnancy
The most well-known medical concern around Rh status involves pregnancy. When an Rh-negative mother carries an Rh-positive baby, small amounts of the baby’s blood can cross the placenta and enter the mother’s bloodstream. Her immune system recognizes the D antigen on those fetal blood cells as foreign and starts producing antibodies against it.
In a first pregnancy, this sensitization process usually happens too late to cause serious harm to the baby. The danger comes in subsequent pregnancies. If the next baby is also Rh positive, the mother’s antibodies (already primed from the first exposure) can cross back through the placenta and attack the baby’s red blood cells. This condition is called hemolytic disease of the fetus and newborn.
Mild cases cause jaundice and anemia in the newborn. Severe cases can lead to a dangerous condition called hydrops fetalis, where fluid accumulates throughout the baby’s body, including around the heart and lungs. When fetal hemoglobin drops far below normal levels, this swelling develops and carries a mortality rate estimated above 50%. In newborns, the rapid breakdown of red blood cells floods the body with bilirubin, a waste product the baby’s immature liver can’t process fast enough. If bilirubin levels climb too high, it can cross into the brain and cause permanent neurological damage.
How It’s Prevented
The good news is that Rh incompatibility is almost entirely preventable. Rh-negative mothers receive an injection of anti-D immunoglobulin (commonly known by the brand name RhoGAM) at 28 to 30 weeks of pregnancy and again within 72 hours after delivery. This injection works by neutralizing any fetal Rh-positive blood cells in the mother’s system before her immune system has a chance to react and form lasting antibodies. When both doses are given on schedule, the risk of sensitization drops to about 0.1%.
If the injection can’t be given within 72 hours after delivery, it can still be administered up to 28 days later and provide some protection. The treatment is also given after miscarriage, ectopic pregnancy, or any other event where fetal blood might mix with the mother’s circulation.
Rh-Null: The Rarest Blood of All
Standard Rh-negative blood simply lacks the D antigen. But an extremely rare variant called Rh-null lacks all Rh antigens, not just D but also the C, c, E, and e antigens that make up the broader Rh system. This blood type occurs in roughly 1 in 6 million people and is sometimes called “golden blood” because of its extreme rarity and its potential value as a universal donor within the Rh system.
Living with Rh-null isn’t entirely benign. The Rh proteins play a structural role in red blood cell membranes, so people without them tend to have red blood cells with abnormal shapes and increased fragility. This leads to mild or moderate chronic anemia. If an Rh-null individual ever needs a transfusion, finding compatible blood is extraordinarily difficult, since exposure to any Rh antigen can trigger antibody production. In practice, they can only safely receive blood from other Rh-null donors, a pool of fewer than 50 known people worldwide.